How Prior Authorization Works for Military and VA GLP-1 Coverage

How Prior Authorization Works for Military and VA GLP-1 Coverage

Prior authorization under a military pharmacy benefit is a form the prescriber downloads for the specific drug, completes and sends to the pharmacy contractor. The VA runs a separate mechanism entirely, a non-formulary request reviewed inside the facility. Both start with the prescriber, neither can be filed by the beneficiary, and the two are not interchangeable.

Three different instruments, often confused

People use the phrase prior authorization for any paperwork standing between a prescription and a filled bottle. Inside these systems it names something narrower, and the distinction determines what gets submitted.

Prior authorization under the TRICARE pharmacy program applies in defined situations: when a drug is specified by the Department of Defense Pharmacy and Therapeutics Committee, when a brand-name product has a generic substitute available, when age limits attach to the product, and when a prescription exceeds the normal quantity limit. It answers whether the benefit will pay at all.

A medical necessity determination is a different instrument aimed at cost share. Non-formulary drugs are covered at a higher cost share than formulary ones, and where a prescriber establishes medical necessity the drug moves to the formulary cost share, or to no cost for active duty service members. Nothing about coverage changes. The price changes.

A VA non-formulary request is the third. The VA National Formulary is maintained by Pharmacy Benefits Management Services and searchable through the VA Formulary Advisor tool. When a clinician believes an agent outside that list is right for a particular veteran, the request is raised and reviewed within the health care system rather than sent to an outside contractor.

Because these instruments get muddled so easily, patient-facing explainers have become a common first stop. Providers such as Ro, Henry Meds and Hims and Hers post overviews of how plans approach these drugs, and HealthRX maintains a page on GLP-1 insurance coverage that separates prior authorization from cost-share appeals in plain terms. Reading one or two builds the vocabulary for a benefit call, though the criteria document attached to the specific drug still decides the outcome.

How the military submission actually moves

The sequence is unusually concrete. The drug is looked up in the formulary search tool, which produces the correct form for that specific product. The prescriber completes it and sends it to Express Scripts, the pharmacy program contractor. Instructions sit on the form itself, and there is no benefit to sending duplicates. That last detail matters because duplicate submissions are a common self-inflicted delay when a beneficiary chases an office that has already filed.

Where an approval applies is worth knowing before anyone celebrates. A prior authorization approval extends to military pharmacies, network pharmacies and home delivery. A medical necessity approval applies at network pharmacies and home delivery. Those are not the same footprint, and a beneficiary planning to fill at a military treatment facility should confirm which instrument was actually approved.

Comparing the three routes

InstrumentSystemQuestion it answersWho reviews itWhere approval applies 
Prior authorizationMilitary pharmacy benefitWill the benefit payPharmacy program contractorMilitary, network and home delivery pharmacies
Medical necessityMilitary pharmacy benefitAt which cost sharePharmacy program contractorNetwork pharmacies and home delivery
Non-formulary requestVA health careCan an off-list agent be usedFacility and network clinical reviewVA pharmacy dispensing

What a reviewer is actually reading

Reviewers work from criteria documents, not from impressions. Requirements for anti-obesity agents are typically assembled from familiar components: the labeled indication, an adiposity measure, documentation of what was tried before, and confirmation that labeled contraindications were considered. The tirzepatide and semaglutide labels both carry a boxed warning regarding thyroid C-cell tumors, and any submission that ignores contraindication screening invites a request for more information.

Specific thresholds and step sequences vary by system, by category of beneficiary and by review cycle, and they are revised. The only reliable source is the criteria attached to the drug in the relevant formulary tool at the time of filing. Working from a number someone quoted in a forum is how a submission comes back incomplete.

The chart is the evidence. A reviewer scores what is written down, so a comorbid condition that exists but was never recorded functions as one that does not exist. Offices that pull the criteria first and assemble to them approve on the first attempt considerably more often than offices that submit and see what happens.

Beneficiary category changes the arithmetic

Active duty service members have no cost for covered drugs at a military pharmacy, home delivery or a retail network pharmacy, and their prescriber must establish medical necessity for non-formulary drugs. Everyone else sits under a structure driven by plan, group and pharmacy type, with deductibles applying in some combinations and not others. Enrolled veterans are outside that scheme altogether, with medication costs tied to priority group, service connection and exemption status.

While a submission is pending

Review takes time, and titration schedules do not pause politely. Some people run a self-pay course in parallel rather than lose the ground already gained, either through a manufacturer’s direct pharmacy for an approved branded product or through a telehealth practice selling a supervised compounded course. Anyone weighing the second option should look past the headline figure to what the monthly price includes and to the provider behind it, because a compounded preparation is not an FDA-approved product and the practice writing the prescription is the only clinical control in that chain.

Approvals are dated

An authorization runs for a defined period. Renewal generally turns on documented benefit, which means weight has to be measured and recorded on a schedule rather than reconstructed at renewal time. That requirement has a clinical basis: maintenance data show the effect of these agents depends on continued treatment rather than persisting once a course stops. Practically, the day an approval letter arrives is the day to put its end date in a calendar.

Questions people ask

Who downloads the form, the patient or the prescriber?

Either can retrieve it from the formulary search tool, since the tool is public. Only the prescriber can complete and submit it, because the content is clinical documentation. A beneficiary who prints the correct form and hands it to the office often shortens the process by several days.

Does a VA non-formulary request work like a commercial prior authorization?

Not really. There is no outside pharmacy benefit manager adjudicating it. The request is raised by the treating clinician and reviewed within the VA health care system, which is why the escalation path afterward runs through clinical channels rather than through a claims appeal to a contractor.

How long should a determination take?

It depends on the system and the instrument. Neither turnaround is a single published number that applies to every beneficiary, so the reliable answer comes from the office that filed the request or from the pharmacy contact for that specific benefit rather than from a general figure found online.

Can an approval be granted then stop working?

Yes. The most common causes are an end date reached without renewal, a formulary category that moved at a scheduled review, or a fill attempted through a channel the approval never covered. All three produce a counter rejection that looks like coverage loss and is not.

Weekly Popular